This company listing is no longer active
Kyto Technology and Life Science Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Paul Russo
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 4.6yrs |
| CEO ownership | 16.8% |
| Management average tenure | no data |
| Board average tenure | 1.8yrs |
Recent management updates
No updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2021 | n/a | n/a | US$652k |
| Sep 30 2021 | n/a | n/a | US$810k |
| Jun 30 2021 | n/a | n/a | US$132k |
| Mar 31 2021 | US$313k | US$100k | US$427k |
| Dec 31 2020 | n/a | n/a | -US$86k |
| Sep 30 2020 | n/a | n/a | -US$172k |
| Jun 30 2020 | n/a | n/a | -US$611k |
| Mar 31 2020 | US$227k | n/a | -US$773k |
Compensation vs Market: Insufficient data to establish whether Paul's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Paul's compensation has been consistent with company performance over the past year.
CEO
Paul Russo (79 yo)
4.6yrs
Tenure
US$313,014
Compensation
Dr. Paul M. Russo, Ph D., has been Chief Executive Officer and Director of KYTO Technology and Life Science, Inc. since April 2018. Dr. Russo serves as Chairman at Kyto Technology and Life Science, Inc. si...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman | 4.6yrs | US$313.01k | 16.81% $ 2.7m | |
| Director & Life Science Advisor | 1.8yrs | US$421.00 | 0.55% $ 90.0k | |
| Independent Director | 1.8yrs | US$491.00 | 0.92% $ 150.0k | |
| Director | 1.8yrs | US$3.86k | 2.38% $ 388.1k |
1.8yrs
Average Tenure
79.5yo
Average Age
Experienced Board: KBPH's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/11/19 16:37 |
| End of Day Share Price | 2022/08/22 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kyto Technology and Life Science, Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.